Adult acute lymphocytic leukemia. Introduction and questions related to current programs

Hematology/Oncology Clinics of North America

Volumn 14, Issue 6, 2000, Pages 1205-1208

  Kantarjian, Hagop M ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTIFUNGAL AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; STEROID; VINCRISTINE;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CENTRAL NERVOUS SYSTEM DISEASE; CHILDHOOD CANCER; CYTOGENETICS; GENE REARRANGEMENT; HUMAN; MAINTENANCE THERAPY; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SALVAGE THERAPY; STEM CELL TRANSPLANTATION;

EID: 0033634907     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70182-9     Document Type: Article

References (20)

1. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia
2. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia
3. The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblstic leukemia
4. Acute lymphoblastic leukemia: Progress in children, less in adults
5. Improved outcome in adult B-cell acute lymphoblastic leukemia
6. Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia
7. Adult acute lymphocytic leukemia: Critical review of current knowledge
8. Results of treatment with hyper-CVAD, dose-intensive regimen, in adult acute lymphocytic leukemia
9. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 8811
10. A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB Study 9111
11. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia
12. Curing children of leukemia
13. Management of adult acute lymphocytic leukemia: Present issues and key challenges
14. Philadelphia-chromosome-positive adult acute lymphocytic leukemia: Characteristics, treatment results, and prognosis in 41 patients
15. Acute lymphoblastic leukemia
16. Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia
17. TEL gene rearrangement in acute lymphoblastic leukemia: A new genetic marker with prognostic significance
18. Hyper-CVAD program in Burkitts-type adult acute lymphoblastic leukemia
19. Relationship between daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemia
20. Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin